255 related articles for article (PubMed ID: 22112354)
1. Diabetes mellitus and vascular endothelial dysfunction: current perspectives.
Tousoulis D; Kampoli AM; Stefanadis C
Curr Vasc Pharmacol; 2012 Jan; 10(1):19-32. PubMed ID: 22112354
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus.
Endemann DH; Schiffrin EL
Curr Hypertens Rep; 2004 Apr; 6(2):85-9. PubMed ID: 15010009
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches.
Tousoulis D; Papageorgiou N; Androulakis E; Siasos G; Latsios G; Tentolouris K; Stefanadis C
J Am Coll Cardiol; 2013 Aug; 62(8):667-76. PubMed ID: 23948511
[TBL] [Abstract][Full Text] [Related]
4. Reversibility of endothelial dysfunction in diabetes: role of polyphenols.
Suganya N; Bhakkiyalakshmi E; Sarada DV; Ramkumar KM
Br J Nutr; 2016 Jul; 116(2):223-46. PubMed ID: 27264638
[TBL] [Abstract][Full Text] [Related]
5. Why does diabetes mellitus increase the risk of cardiovascular disease?
Shahab A
Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030
[TBL] [Abstract][Full Text] [Related]
6. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus.
Shemyakin A; Kövamees O; Rafnsson A; Böhm F; Svenarud P; Settergren M; Jung C; Pernow J
Circulation; 2012 Dec; 126(25):2943-50. PubMed ID: 23183942
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and endothelial dysfunction in vascular disease.
Pennathur S; Heinecke JW
Curr Diab Rep; 2007 Aug; 7(4):257-64. PubMed ID: 17686400
[TBL] [Abstract][Full Text] [Related]
8. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide in matrix remodeling in diabetes and heart failure.
Tyagi SC; Hayden MR
Heart Fail Rev; 2003 Jan; 8(1):23-8. PubMed ID: 12652156
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
11. Causation, prevention and reversal of vascular endothelial dysfunction.
Lele RD
J Assoc Physicians India; 2007 Sep; 55():643-51. PubMed ID: 18051738
[TBL] [Abstract][Full Text] [Related]
12. The impact of diabetes mellitus on coronary artery disease: new therapeutic approaches.
Tousoulis D; Kampoli AM; Papageorgiou N; Papaoikonomou S; Antoniades C; Stefanadis C
Curr Pharm Des; 2009; 15(17):2037-48. PubMed ID: 19519440
[TBL] [Abstract][Full Text] [Related]
13. Endothelial nitric oxide in diabetes mellitus: too much or not enough?
Farkas K; Sármán B; Jermendy G; Somogyi A
Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in diabetes mellitus.
Hadi HA; Suwaidi JA
Vasc Health Risk Manag; 2007; 3(6):853-76. PubMed ID: 18200806
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelium dysfunction: a conservative target in metabolic disorders.
Jamwal S; Sharma S
Inflamm Res; 2018 May; 67(5):391-405. PubMed ID: 29372262
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategies targeting endothelial function in humans: clinical implications.
Lee R; Channon KM; Antoniades C
Curr Vasc Pharmacol; 2012 Jan; 10(1):77-93. PubMed ID: 22112349
[TBL] [Abstract][Full Text] [Related]
17. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.
Tabit CE; Chung WB; Hamburg NM; Vita JA
Rev Endocr Metab Disord; 2010 Mar; 11(1):61-74. PubMed ID: 20186491
[TBL] [Abstract][Full Text] [Related]
18. [Endothelial dysfunction: mechanisms of development and therapeutic options].
Pesić S; Radenković M; Grbović L
Med Pregl; 2006; 59(7-8):335-41. PubMed ID: 17140033
[TBL] [Abstract][Full Text] [Related]
19. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis.
Candido R; Zanetti M
Ital Heart J; 2005 Sep; 6(9):703-20. PubMed ID: 16212072
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and vascular disease: basic concepts of nitric oxide physiology, endothelial dysfunction, oxidative stress and therapeutic possibilities.
Capellini VK; Celotto AC; Baldo CF; Olivon VC; Viaro F; Rodrigues AJ; Evora PR
Curr Vasc Pharmacol; 2010 Jul; 8(4):526-44. PubMed ID: 19485895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
